PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS

pharmacoeconomic study of treatment primary open-angle glaucoma with combinations of prostaglandin analogues and beta-blockers by mean of cost-efficacy and budget impact analysis. Results have shown, that Duotrav (travoprost+timolol) has benefits compare with Xalacom (latanoprost+timolol) from cost-...

Full description

Bibliographic Details
Main Authors: A. Yu. Kulikov, V. G. Serpikov
Format: Article
Language:Russian
Published: IRBIS LLC 2015-03-01
Series:Фармакоэкономика
Subjects:
primary open-angle glaucoma
pharmacoeconomic studies
cost-efficacy analysis
budget impact analysis
duotrav
xalacom
travoprost
latanoprost
timolol
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/31
Description
Summary:pharmacoeconomic study of treatment primary open-angle glaucoma with combinations of prostaglandin analogues and beta-blockers by mean of cost-efficacy and budget impact analysis. Results have shown, that Duotrav (travoprost+timolol) has benefits compare with Xalacom (latanoprost+timolol) from cost-efficacy perspective and can be claimed dominant. Futhermore Doutrav in comparison with Xalacom provides cost-saving and advantage in terms of budget impact analysis
ISSN:2070-4909
2070-4933

Similar Items